Insider Sale: Chief Commercial Officer of $LQDA (LQDA) Sells 546 Shares
Scott Moomaw, the Chief Commercial Officer of $LQDA ($LQDA), sold 546 shares of the company on 12-02-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.4%...
Insider Sale: General Counsel of $LQDA (LQDA) Sells 1,063 Shares
Russell Schundler, the General Counsel of $LQDA ($LQDA), sold 1,063 shares of the company on 12-02-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.2% of...
United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics’ Patent
ANAVASI DIAGNOSTICS ANNOUNCES NEWLY ELECTED OUTSIDE BOARD OF DIRECTORS
/PRNewswire/ -- Anavasi Diagnostics ('Anavasi'), an NIH/RADx medical technology company focused on the development of novel molecular diagnostic testing,...
Why Liquidia Stock Rocketed Nearly 21% Higher Today
Investors were obviously cheered by a round of insider buying.
Why Liquidia Shares Rose 18.4% on Monday
Optimism by the company regarding a patent ruling is encouraging investors.